Author

J. Livingstone

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:whole-genome sequencing· 2 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1

Frequent Co-Authors

J. van Riet· 2 shared P. C. Boutros· 2 shared T. N. Yamaguchi· 2 shared A. Gusev· 1 shared A. J. Costello· 1 shared A. M. Bergman· 1 shared A. U. Kishan· 1 shared B. J. Pope· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. van Riet

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Germline determinants of the prostate tumor genome

K. E. Houlahan, J. Yuan, T. Schwarz, J. Livingstone, N. S. Fox, W. Jaratlerdsiri, J. van Riet, K. Taraszka, N. Kurganovs, H. Zhu, J. Sietsma Penington, C.-H. Jung, T. N. Yamaguchi, J. Jiang, L. E. Heisler, , P. C. Boutros

The paper identifies germline-determined quantitative trait loci (dQTLs) that influence somatic mutational features in prostate cancer, revealing their impact on tumor epigenome, transcriptome, and proteome.

bioRxiv · Nov 16, 2022 · PreprintCancer Biology

The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

L. F. van Dessel, J. van Riet, M. Smits, Y. Zhu, P. Hamberg, M. S. van der Heijden, A. M. Bergman, I. M. van Oort, R. de Wit, E. E. Voest, N. Steeghs, T. N. Yamaguchi, J. Livingstone, P. C. Boutros, J. W. M. Martens, , M. P. Lolkema

This study uses whole-genome sequencing to identify four distinct genotypes in metastatic castration-resistant prostate cancers, with potential clinical implications for patient stratification.

bioRxiv · Oct 7, 2019Cancer Biology